Filing Details

Accession Number:
0000905148-18-000728
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-17 21:00:38
Reporting Period:
2018-08-15
Accepted Time:
2018-08-17 21:00:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1399529 Dicerna Pharmaceuticals Inc DRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1274225 Dennis Langer C/o Dicerna Pharmaceuticals, Inc.
87 Cambridgepark Drive
Cambridge MA 02140
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-08-15 23,810 $16.00 47,978 No 4 S Indirect Langer Family Holdings, LLLP
Common Stock Disposition 2018-08-15 14,531 $16.00 29,064 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Langer Family Holdings, LLLP
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2018.
  2. The reporting person disclaims beneficial ownership of the shares owned by Langer Family Holdings, LLLP.